| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PPD, Inc. | EVP of Global Clinical Development | Common Stock | 0 | $47.50 | 08 Dec 2021 | Direct | |
| PPD, Inc. | EVP of Global Clinical Development | Stock Options (Right to Buy) | 0 | $36.91 | 08 Dec 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PPD | PPD, Inc. | 08 Dec 2021 | 7 | -$17,883,134 | 4 | EVP of Global Clinical Development | 08 Dec 2021, 15:41 |